X About BioCanRx Governance
  • Board of Directors
  • Research Management Committee
  • HQP Development Committee
  • Point-of-Care Cell Manufacturing Committee
  • Equity, Diversity, & Inclusion Committee
  • Cancer Stakeholder Alliance
  • CSA Working Group
Equity, Diversity & Inclusion Network Members and Investigators Our Team
X
  • ABOUT
    • About BioCanRx
    • Governance
      • Board of Directors
      • Research Management Committee
      • Point-of-Care Cell Manufacturing Committee
      • Equity, Diversity, & Inclusion Committee
      • Cancer Stakeholder Alliance
        • CSA Working Group
        • Joint Action Plan
        • The Learning Institute
    • Equity, Diversity & Inclusion
    • Network Members
    • Our Team
  • RESEARCH
    • Bridging the Gap
      • Catalyst Projects
      • Enabling Projects
      • Clinical Trials
      • Clinical, Social and Economic Impact Projects
    • Advancing Therapeutic Development
    • Research Program
    • CAR T Platform
      • CAR T Therapy Timeline
    • Application process and instructions
    • Researcher Profiles
  • TRAINING
    • Cultivating Biotherapeutics Expertise
    • Upcoming Learning Opportunities
    • Webinar & Workshop Archives
    • Travel Awards & Lab Exchanges
    • Summer Student Internship
    • Where Are They Now
    • Get Involved!
  • PATIENTS
    • Empowering the Cancer Community
      • Cancer Stakeholder Alliance
        • CSA Working Group
    • Improving Accessibility
    • The Patient Experience
    • Public Forums
    • Resources
      • Immunotherapy 101
      • Glossary
      • BioCanRx-funded Clinical Trials
    • The Learning Institute
  • BIOMANUFACTURING
    • Building Canadian Capacity
    • Core and Biomanufacturing Facilities
  • COMMERCIALIZATION
    • Supporting Homegrown Scale-up
    • Partners
  • SUMMIT4CI
    • About Summit4CI
    • The Learning Institute
    • Summit Speaker Series
| fr
EDI | Partners | News | Events
EDI | Partners | News | Events
| fr
  • ABOUT
    • About BioCanRx
    • Governance
      • Board of Directors
      • Research Management Committee
      • HQP Development Committee
      • Point-of-Care Cell Manufacturing Committee
      • Equity, Diversity, & Inclusion Committee
      • Cancer Stakeholder Alliance
        • CSA Working Group
    • Equity, Diversity & Inclusion
      • BioCanRx EDI Priorities & Action Plan
      • BioCanRx Code of Conduct
      • LOOP Reporting Tool
    • Privacy Policy
    • Network Members
    • Our Team
  • SUMMIT4CI
    • The Learning Institute
    • Summit Speaker Series
  • COMMERCIALIZATION
    • Supporting Homegrown Scale-up
    • Partners
      • Working with us
  • BIOMANUFACTURING
    • Building Canadian Capacity
    • Core and Biomanufacturing Facilities
  • PATIENTS
    • Empowering the Cancer Community
      • Cancer Stakeholder Alliance
        • CSA Working Group
    • Improving Accessibility
    • The Patient Experience
    • Public Forums
    • Resources
      • Immunotherapy 101
      • Glossary
      • BioCanRx-funded Clinical Trials
    • The Learning Institute
  • TRAINING
    • Cultivating Biotherapeutics Expertise
    • Learning Resources
      • Upcoming Learning Opportunities
      • Webinar & Workshop Archives
    • Opportunities
      • Summer Student Internships
        • Indigenous Student Summer Internship
        • Summer Student Internship
      • Travel Awards & Lab Exchanges
    • External Resources
    • Where Are They Now
    • Get Involved!
  • RESEARCH
    • Bridging the Gap
    • Advancing Therapeutic Development
    • Research Projects
      • Catalyst Projects
      • Enabling Projects
      • Clinical Trials
      • CSEI Projects
    • Research Program
      • Areas of Research
      • Program Descriptions
      • Open Call 2024
    • CAR T Platform
      • CAR T Therapy Timeline
    • Researcher Profiles
 

Christopher Paige

thumb image

Senior Scientist, Princess Margaret Cancer Centre

 

Full Biography

 

Cancers of Interest

Leukemia

 

Research and clinical approaches

Preclinical development of cancer vaccines

 

Projects at BioCanRx

PHASE I STUDY OF THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) USING AUTOLOGOUS AML CELLS ENGINEERED TO EXPRESS IL-12

Blood cancer Immunotherapy

  • ABOUT
    • About BioCanRx
    • Governance
    • Board of Directors
    • Research Management Committee
    • Point-of-Care Cell Manufacturing Committee
    • Equity, Diversity, & Inclusion Committee
    • Cancer Stakeholder Alliance
    • CSA Working Group
    • Equity, Diversity & Inclusion
    • BioCanRx EDI Priorities & Action Plan
    • BioCanRx Code of Conduct
    • LOOP Reporting Tool
    • Privacy policy
    • Network Members
    • Our Team
  • RESEARCH
    • Bridging the Gap
    • Advancing Therapeutic Development
    • Catalyst Projects
    • Enabling Projects
    • Clinical Trials
    • Clinical, Social and Economic Impact Projects
    • Areas of Research
    • Program Descriptions
    • Made-in-Canada CAR T Platform
    • Made-in-Canada CAR T Therapy Timeline
    • Researcher Profiles
  • TRAINING
    • Cultivating Biotherapeutics Expertise
    • Upcoming Learning Opportunities
    • Webinar & Workshop Archives
    • Summer Student Internships
    • Indigenous Student Summer Internship
    • Summer Student Internship
    • Travel Awards & Lab Exchanges
    • External Resources
    • Where Are They Now
    • Get Involved!
  • PATIENTS
    • Empowering the Cancer Community
    • Improving Accessibility
    • Patient Experience
    • Public Forums
    • Resources
    • Immunotherapy 101
    • Glossary
    • BioCanRx-funded Clinical Trials
    • The Learning Institute
  • BIOMANUFACTURING
    • Building Canadian Capacity
    • Core and Biomanufacturing Facilities
  • COMMERCIALIZATION
    • Supporting Homegrown Scale-up
    • Partners
  • SUMMIT4CI
    • The Learning Institute
    • Summit4CI Speaker Series
Diversio Link IDEAL

Box 611, 501 Smyth Road
Ottawa, ON K1H 8L6
info@biocanrx.com

Last modified date: Jun 17, 2024
Copyright 2024, All rights reserved
  • ABOUT
    • Governance
      • Board of Directors
      • Research Management Committee
      • Point-of-Care Cell Manufacturing Committee
      • Equity, Diversity, & Inclusion Committee
      • Cancer Stakeholder Alliance
        • CSA Working Group
    • Equity, Diversity & Inclusion
      • BioCanRx EDI Priorities & Action Plan
      • BioCanRx Code of Conduct
      • LOOP Reporting Tool
    • Privacy Policy
    • Network Members and Investigators
    • Our Team
  • RESEARCH
    • Bridging the Gap
    • Advancing Therapeutic Development
    • Research Projects
      • Catalyst Projects
      • Enabling Projects
      • Clinical Trials
      • Clinical, Social and Economic Impact Projects
    • Research Program
      • Areas of Research
      • Program Descriptions
      • Open Call 2024
    • CAR T Platform
      • CAR T Therapy Timeline
    • Researcher Profiles
  • TRAINING
    • Cultivating Biotherapeutics Expertise
    • Learning Resources
      • Upcoming Learning Opportunities
      • Webinar & Workshop Archives
    • Opportunities
      • Summer Student Internships
        • Indigenous Student Summer Internship
        • Summer Student Internship
      • Travel Awards & Lab Exchanges
    • External Resources
    • Where Are They Now
    • Get Involved!
  • PATIENTS
    • Empowering the Cancer Community
      • Cancer Stakeholder Alliance
        • CSA Working Group
    • Improving Accessibility
    • The Patient Experience
    • Public Forums
    • Resources
      • Immunotherapy 101
      • Glossary
      • BioCanRx-funded Clinical Trials
    • The Learning Institute
  • BIOMANUFACTURING
    • Building Canadian Capacity
    • Core and Biomanufacturing Facilities
  • COMMERCIALIZATION
    • Supporting Homegrown Scale-up
    • Our Partners
  • SUMMIT4CI
    • The Learning Institute
    • Summit Speaker Series